Vasomune Therapeutics advances vascular leak therapy as FDA allows pegevongitide burn trial program
FDA clears Vasomune Therapeutics’ IND for pegevongitide in severe burn resuscitation. Explore what this Tie2 therapy could change for vascular leak treatment.